Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies
about
Human polyomavirus reactivation: disease pathogenesis and treatment approachesNew and emerging disease modifying therapies for multiple sclerosisStructural specializations of α(4)β(7), an integrin that mediates rolling adhesionMolecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainUpdate on CD40 and CD154 blockade in transplant modelsNew insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathyJC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?Progressive multifocal leukoencephalopathy: clinical and molecular aspectsThe importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathyIlluminating viral infections in the nervous systemBiology and structure of leukocyte β 2 integrins and their role in inflammationImmune System Involvement in the Pathogenesis of JC Virus Induced PML: What is Learned from Studies of Patients with Underlying Diseases and Therapies as Risk FactorsMultiple Sclerosis and T Lymphocytes: An Entangled StoryReduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarateTherapeutic decisions in multiple sclerosis: moving beyond efficacyT cell epitope mapping of JC polyoma virus-encoded proteome reveals reduced T cell responses in HLA-DRB1*04:01+ donorsProgressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.A link between long-term natalizumab dosing in MS and PML: Putting the puzzle togetherUse of monoclonal antibodies in renal transplantation.MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study.α4-integrins control viral meningoencephalitis through differential recruitment of T helper cell subsets.Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production.Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2Emergence and re-emergence of viral diseases of the central nervous system.Assessing long-term drug safety: lessons (re) learned from raptiva.Viral encephalomyelitis.Ibudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cellsSafety and immunotoxicity assessment of immunomodulatory monoclonal antibodiesIslet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activityActivation of c-Myc and Cyclin D1 by JCV T-Antigen and β-catenin in colon cancer.Viral miRNAs in plasma and urine divulge JC polyomavirus infection.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of thePre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant.Exclusive antagonism of the α4 β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates.Hexadecyloxypropyl-cidofovir (CMX001) suppresses JC virus replication in human fetal brain SVG cell cultures.Antibodies reacting with JCPyV_VP2 _167-15mer as a novel serological marker for JC polyomavirus infection.Essential roles of Leu/Ile/Phe-rich domain of JC virus agnoprotein in dimer/oligomer formation, protein stability and splicing of viral transcripts
P2860
Q21285083-6255EA9D-B211-4638-9517-C4F55CF3102DQ22242305-7439B809-2FFD-4465-9389-B45751BD8DE0Q24611768-AFB3B278-2B2E-4CD8-8F94-62DE3972E281Q24619923-707DB4E5-690D-492B-A71F-8A424B06B2C8Q26798362-76AD65C0-244D-43E8-AAB3-FE6892501445Q26822247-6F1938A4-294F-4BA0-9E00-90C6F37A52B3Q26852060-327BC2A1-077D-4BE6-B417-D428E72A766DQ26858968-70C441BA-3F08-4063-8B9C-7B78CF7527D0Q26859307-E6BDD2FD-16B9-450A-9558-8477DFA247B3Q27310280-404C7555-7FD3-49F2-8D7D-C7878232DF9DQ28079100-AF2DBE82-7D5B-429A-92AC-B64FDCE5BBA1Q28085415-F45B796F-D259-48EF-A6DC-11E38877C196Q28086853-C12E23E2-BCC7-44B0-A8F9-92A20C884D88Q28388243-583128A2-EDF0-4D2F-9F39-9DD17A0D7CE8Q28541039-2BD5B3F5-22D6-43D3-8DAE-604B3DADE8D0Q28704590-5EC59781-76D8-49DE-8204-686F7C8B5227Q30235523-FB880533-F0DA-4954-A8B1-C15ADE80EB01Q33363188-D91945F2-ACB3-40D0-AC34-336854FF3DF8Q33396236-80D15CD7-E044-4B03-9BB8-D3B8B6928DBFQ33571905-1037E4D5-D35F-40C6-9A2C-817CF23FC342Q33642954-10CA48AC-A1EF-470E-B84F-106CFFC847C3Q33649838-265E33A0-88DD-427A-B797-E02DE66D64A4Q33664396-AB2AD576-5E6B-42FB-AE9D-3F01D55C3E7AQ33812013-2E5348F7-9C43-44B8-9A4B-A2F935015227Q33831065-8A10C6EC-2A36-40B1-8153-B541B0A57498Q33859519-67D72763-6A19-4C44-BB55-38061D33972EQ33873538-56C3593D-5866-4D6F-9A02-E0D4727E0112Q33895804-45085669-19AC-4295-852B-9412BDA33963Q34026630-87F1E002-07A0-453D-B04B-DCAABAF4736EQ34110804-8EAD72C4-6E54-4B95-B415-5A62CADA81A3Q34136900-3D51F781-620E-4B39-AF7E-D7D706972BC1Q34205870-2D2CB385-5935-4DDC-B965-B93E5031D420Q34208184-0F50EAB5-561A-4544-8D34-283FAEC4F95EQ34212799-9A42881B-71F6-413B-94EA-B90A6100699DQ34230150-67EED168-3C8C-4645-B1E0-F2DCCA0CA7B6Q34247539-2AA7972F-4395-4AC2-B4AC-7C2F7206073FQ34261526-CBD9769C-91EC-4E8D-A111-61CAB94F6233Q34290158-C16FADA1-1AC9-4539-9B76-B32C85F41D75Q34325718-7FE49B4E-2F6F-44A3-9911-764ECC847DD4Q34349454-71131125-6DF6-4549-A553-5758868866EE
P2860
Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies
@ast
Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies
@en
Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies
@nl
type
label
Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies
@ast
Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies
@en
Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies
@nl
prefLabel
Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies
@ast
Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies
@en
Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies
@nl
P3181
P1476
Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies
@en
P2093
Eugene O Major
P3181
P356
10.1146/ANNUREV.MED.080708.082655
P407
P577
2010-01-01T00:00:00Z